BioCryst Pharmaceuticals, Inc.
BCRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $84,078 | $88,033 | $105,481 | $104,923 |
| Short-Term Investments | $128,795 | $172,005 | $189,902 | $216,137 |
| Receivables | $91,325 | $91,177 | $93,394 | $79,069 |
| Inventory | $5,232 | $5,044 | $6,873 | $8,087 |
| Other Curr. Assets | $46,254 | $42,203 | $14,327 | $13,752 |
| Total Curr. Assets | $355,684 | $398,462 | $409,977 | $421,968 |
| Property Plant & Equip (Net) | $19,236 | $20,003 | $19,575 | $19,785 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $39,669 | $10,101 | $21,948 | $21,723 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $31,835 | $28,622 | $28,547 | $26,944 |
| Total NC Assets | $90,740 | $58,726 | $70,070 | $68,452 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $446,424 | $457,188 | $480,047 | $490,420 |
| Liabilities | – | – | – | – |
| Payables | $5,567 | $8,589 | $10,049 | $11,644 |
| Short-Term Debt | $39,469 | $2,008 | $37,171 | $35,448 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $145,201 | $166,563 | $92,635 | $113,292 |
| Total Curr. Liab. | $190,237 | $177,160 | $139,855 | $160,384 |
| LT Debt | $643,640 | $701,168 | $792,119 | $805,970 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $436 | $454 | $0 | $0 |
| Total NC Liab. | $644,076 | $701,622 | $792,119 | $805,970 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $11,950 | $12,540 | $10,093 | $10,048 |
| Total Liabilities | $834,313 | $878,782 | $931,974 | $966,354 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2,105 | $2,099 | $2,092 | $2,085 |
| Retained Earnings | -$1,752,024 | -$1,764,923 | -$1,770,008 | -$1,770,040 |
| AOCI | $1,140 | $1,646 | $1,132 | $921 |
| Other Equity | $1,360,890 | $1,339,584 | $1,314,857 | $1,291,100 |
| Total Equity | -$387,889 | -$421,594 | -$451,927 | -$475,934 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $446,424 | $457,188 | $480,047 | $490,420 |
| Net Debt | $599,031 | $615,143 | $723,809 | $736,495 |